Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Neil Aggarwal

Concepts (337)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oxygen
10
2026
978
2.390
 Why?
Outpatients
5
2024
447
1.920
 Why?
Antiviral Agents
6
2026
769
1.680
 Why?
Acute Lung Injury
11
2015
305
1.190
 Why?
Adenosine Monophosphate
4
2026
85
1.180
 Why?
Macrophages, Alveolar
5
2016
373
1.150
 Why?
Hypoxia
7
2026
1199
1.120
 Why?
Alanine
3
2025
169
1.100
 Why?
Pneumonia
7
2025
636
0.990
 Why?
Intensive Care Units
5
2026
924
0.910
 Why?
Hospitalization
10
2026
2460
0.910
 Why?
Hyperoxia
1
2026
96
0.880
 Why?
Respiration, Artificial
4
2026
713
0.860
 Why?
Oxygen Inhalation Therapy
4
2026
181
0.830
 Why?
T-Lymphocytes, Regulatory
5
2015
409
0.790
 Why?
Interleukin-6
4
2026
776
0.770
 Why?
Critical Illness
8
2026
900
0.750
 Why?
National Heart, Lung, and Blood Institute (U.S.)
6
2021
103
0.670
 Why?
Respiratory Insufficiency
4
2026
326
0.660
 Why?
Intubation, Intratracheal
3
2026
325
0.550
 Why?
Phagocytes
1
2018
80
0.510
 Why?
Positive-Pressure Respiration
1
2018
115
0.510
 Why?
Lung Injury
3
2026
244
0.500
 Why?
Leukocytes, Mononuclear
1
2018
574
0.430
 Why?
Smoke
1
2016
148
0.430
 Why?
Lung
12
2018
4106
0.430
 Why?
Adult
24
2026
40777
0.390
 Why?
Receptor, Adenosine A2A
1
2013
23
0.390
 Why?
Lipopolysaccharides
9
2015
858
0.360
 Why?
Immunity, Innate
1
2018
835
0.350
 Why?
Antibodies, Viral
3
2024
674
0.350
 Why?
Humans
52
2026
145474
0.340
 Why?
Aged
20
2026
26153
0.340
 Why?
Multicenter Studies as Topic
4
2026
412
0.340
 Why?
Antibodies, Monoclonal
5
2024
1505
0.320
 Why?
Bacteria
1
2016
765
0.320
 Why?
Hydroxychloroquine
2
2020
65
0.310
 Why?
Smoking
2
2016
1472
0.310
 Why?
Mice, Inbred C57BL
16
2025
5983
0.310
 Why?
Male
35
2026
72842
0.300
 Why?
Research Report
2
2021
86
0.300
 Why?
Middle Aged
20
2026
36215
0.290
 Why?
Pneumonia, Viral
2
2026
389
0.280
 Why?
Coronavirus Infections
2
2026
383
0.270
 Why?
Macrophages
1
2016
1507
0.270
 Why?
Bronchoalveolar Lavage Fluid
7
2013
638
0.270
 Why?
Flow Cytometry
3
2018
1162
0.270
 Why?
Epithelial Cells
4
2016
1131
0.250
 Why?
Inflammation Mediators
4
2016
506
0.250
 Why?
Vaccination
2
2024
1426
0.250
 Why?
Wound Healing
1
2009
355
0.250
 Why?
Mice
15
2025
18329
0.250
 Why?
Neuromuscular Nondepolarizing Agents
1
2026
33
0.240
 Why?
Androstanols
1
2026
30
0.240
 Why?
Mice, Knockout
8
2015
3124
0.230
 Why?
Immunophenotyping
2
2018
319
0.230
 Why?
Carotid Artery, Internal
1
2006
45
0.230
 Why?
Antibodies, Neutralizing
3
2023
340
0.230
 Why?
Etomidate
1
2025
21
0.230
 Why?
Colorado
3
2025
4553
0.230
 Why?
Hospitals, Community
1
2026
67
0.230
 Why?
Pragmatic Clinical Trials as Topic
1
2026
133
0.230
 Why?
Utah
1
2025
79
0.230
 Why?
Carotid Artery Diseases
1
2006
70
0.230
 Why?
Critical Care
2
2024
702
0.220
 Why?
Phagocytosis
2
2018
296
0.220
 Why?
Randomized Controlled Trials as Topic
4
2026
1747
0.220
 Why?
Sepsis
2
2024
664
0.220
 Why?
Lymphopenia
1
2025
62
0.210
 Why?
Intracranial Aneurysm
1
2006
106
0.210
 Why?
Animals
19
2025
38030
0.210
 Why?
Ketamine
1
2025
137
0.210
 Why?
Health Care Rationing
1
2024
56
0.210
 Why?
Organ Dysfunction Scores
1
2024
55
0.210
 Why?
Hospital Mortality
2
2025
1038
0.200
 Why?
Multiple Organ Failure
1
2024
120
0.200
 Why?
Lung Diseases
2
2021
780
0.200
 Why?
Antigens, Viral
1
2024
182
0.200
 Why?
Female
21
2026
78844
0.200
 Why?
Noninvasive Ventilation
1
2024
62
0.190
 Why?
Biomedical Research
2
2021
717
0.190
 Why?
Research Design
2
2026
1137
0.190
 Why?
Analgesics, Non-Narcotic
1
2024
128
0.190
 Why?
Public-Private Sector Partnerships
2
2021
44
0.190
 Why?
Gene Expression Profiling
1
2009
1767
0.190
 Why?
Sleep Deprivation
1
2025
206
0.180
 Why?
Ritonavir
1
2023
75
0.180
 Why?
Polycystic Kidney, Autosomal Dominant
1
2006
235
0.180
 Why?
Pulmonary Circulation
2
2021
430
0.180
 Why?
Proportional Hazards Models
1
2025
1327
0.180
 Why?
Acetaminophen
1
2024
267
0.170
 Why?
Cytokines
3
2016
2067
0.170
 Why?
Retrospective Studies
6
2025
17291
0.170
 Why?
Pandemics
4
2026
1707
0.170
 Why?
Cell Membrane Permeability
2
2012
88
0.170
 Why?
Education
1
2021
104
0.160
 Why?
Electronic Health Records
2
2026
1196
0.160
 Why?
RNA, Viral
1
2024
692
0.160
 Why?
Pulmonary Alveoli
3
2015
385
0.150
 Why?
Triglycerides
2
2013
520
0.150
 Why?
Tidal Volume
2
2018
109
0.150
 Why?
Neutrophils
4
2015
1124
0.150
 Why?
Antibodies
1
2021
397
0.150
 Why?
Disease Models, Animal
6
2025
4560
0.140
 Why?
Serum Bactericidal Test
1
2018
1
0.140
 Why?
Financing, Government
1
2019
53
0.140
 Why?
Ventricular Function, Right
1
2021
297
0.140
 Why?
Machine Learning
1
2024
587
0.140
 Why?
United States
11
2026
16098
0.140
 Why?
Interinstitutional Relations
1
2018
55
0.140
 Why?
Rare Diseases
1
2019
116
0.140
 Why?
Partial Pressure
1
2018
30
0.140
 Why?
Vascular Diseases
1
2021
252
0.140
 Why?
Severity of Illness Index
3
2025
2930
0.140
 Why?
Blood Gas Analysis
1
2018
81
0.130
 Why?
APACHE
1
2018
68
0.130
 Why?
Treatment Outcome
8
2026
11772
0.130
 Why?
Systemic Inflammatory Response Syndrome
1
2018
95
0.130
 Why?
Streptococcus
1
2018
29
0.130
 Why?
Betacoronavirus
1
2020
288
0.130
 Why?
Biomarkers
4
2026
4295
0.130
 Why?
Precision Medicine
1
2021
459
0.120
 Why?
Endothelial Cells
2
2016
874
0.120
 Why?
Cell Separation
1
2018
305
0.120
 Why?
Macrophage Activation
1
2018
181
0.120
 Why?
Adoptive Transfer
3
2015
200
0.120
 Why?
Disease Susceptibility
1
2018
344
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2022
992
0.120
 Why?
Soot
1
2016
23
0.120
 Why?
Goals
1
2018
184
0.120
 Why?
Research
1
2019
430
0.120
 Why?
Chemokines
2
2015
217
0.120
 Why?
Leukocytosis
1
2015
32
0.110
 Why?
DNA Modification Methylases
1
2015
18
0.110
 Why?
Wasting Syndrome
1
2015
12
0.110
 Why?
Nitric Oxide Synthase Type II
2
2012
162
0.110
 Why?
Muscular Atrophy
2
2015
87
0.110
 Why?
Epithelium
1
2016
310
0.110
 Why?
Lung Transplantation
1
2018
332
0.110
 Why?
Interview, Psychological
1
2015
95
0.110
 Why?
Interleukin-10
2
2014
309
0.110
 Why?
Lipoprotein Lipase
2
2013
56
0.110
 Why?
Tissue and Organ Procurement
1
2018
343
0.100
 Why?
Air Pollution, Indoor
1
2016
171
0.100
 Why?
Ubiquitin-Protein Ligases
2
2015
192
0.100
 Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2015
231
0.100
 Why?
Muscle Proteins
2
2015
242
0.100
 Why?
Societies, Medical
1
2018
899
0.100
 Why?
Azacitidine
1
2015
157
0.100
 Why?
Cells, Cultured
4
2016
4148
0.100
 Why?
Lipoproteins
2
2013
166
0.100
 Why?
Particulate Matter
1
2016
326
0.100
 Why?
Phenethylamines
1
2013
16
0.100
 Why?
Osteomyelitis
1
2015
145
0.100
 Why?
Adenosine A2 Receptor Agonists
1
2013
23
0.100
 Why?
Forkhead Transcription Factors
2
2015
207
0.090
 Why?
Bacteremia
1
2015
222
0.090
 Why?
Gene Knockout Techniques
1
2013
119
0.090
 Why?
Physical Conditioning, Animal
1
2015
242
0.090
 Why?
Aquaporin 5
1
2012
3
0.090
 Why?
Adaptive Clinical Trials as Topic
2
2022
24
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
977
0.090
 Why?
Air Pollutants
1
2016
405
0.090
 Why?
Pulmonary Disease, Chronic Obstructive
2
2016
919
0.090
 Why?
Enzyme Inhibitors
1
2015
820
0.090
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 2
1
2011
1
0.090
 Why?
Adenosine
1
2013
255
0.080
 Why?
Time Factors
5
2016
7123
0.080
 Why?
Capillary Permeability
1
2011
132
0.080
 Why?
Staphylococcal Infections
1
2015
391
0.080
 Why?
Aftercare
2
2023
222
0.080
 Why?
Heart Arrest
2
2025
410
0.080
 Why?
Treatment Failure
2
2022
360
0.080
 Why?
Double-Blind Method
2
2026
2062
0.080
 Why?
Longitudinal Studies
1
2018
2953
0.080
 Why?
Exercise Therapy
1
2015
475
0.080
 Why?
Family
1
2015
682
0.080
 Why?
Genes, RAG-1
1
2009
11
0.080
 Why?
Microtubules
1
2012
265
0.080
 Why?
Leukocyte Reduction Procedures
1
2009
29
0.080
 Why?
HIV-1
1
2016
908
0.080
 Why?
Hypertension, Pulmonary
1
2021
1957
0.080
 Why?
Monocytes
1
2012
539
0.070
 Why?
Interleukin-2 Receptor alpha Subunit
1
2009
82
0.070
 Why?
Phenotype
3
2026
3155
0.070
 Why?
Dose-Response Relationship, Drug
2
2026
2028
0.070
 Why?
Leukocyte Count
1
2009
316
0.070
 Why?
Cluster Analysis
1
2009
500
0.070
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
749
0.070
 Why?
Heart Failure
1
2021
2326
0.070
 Why?
Muscle, Skeletal
2
2015
1789
0.060
 Why?
T-Lymphocyte Subsets
1
2009
418
0.060
 Why?
Gene Regulatory Networks
1
2009
317
0.060
 Why?
Prospective Studies
4
2026
8057
0.060
 Why?
Cohort Studies
3
2024
6013
0.060
 Why?
Sleep Apnea, Obstructive
1
2011
302
0.060
 Why?
Adipose Tissue
1
2011
645
0.060
 Why?
Pulmonary Surfactant-Associated Protein D
1
2026
31
0.060
 Why?
Receptor for Advanced Glycation End Products
1
2026
33
0.060
 Why?
Triazines
1
2026
49
0.060
 Why?
Indazoles
1
2026
85
0.060
 Why?
Patient Discharge
2
2023
992
0.060
 Why?
Mental Disorders
1
2015
1163
0.060
 Why?
Anesthetics, Dissociative
1
2025
46
0.060
 Why?
Anesthetics, Intravenous
1
2025
69
0.060
 Why?
Oximetry
1
2026
125
0.050
 Why?
Triazoles
1
2026
187
0.050
 Why?
Lymphocyte Count
1
2025
164
0.050
 Why?
Homeodomain Proteins
3
2015
523
0.050
 Why?
Gene Expression Regulation
2
2012
2597
0.050
 Why?
Receptors, CXCR4
2
2016
91
0.050
 Why?
Data Interpretation, Statistical
1
2026
368
0.050
 Why?
C-Reactive Protein
1
2026
422
0.050
 Why?
Renal Replacement Therapy
1
2024
100
0.050
 Why?
Phentolamine
1
2023
19
0.050
 Why?
Masks
1
2024
70
0.050
 Why?
Tripartite Motif Proteins
2
2015
39
0.050
 Why?
Vasoactive Intestinal Peptide
1
2023
20
0.050
 Why?
United States Food and Drug Administration
1
2024
208
0.050
 Why?
Tomography, X-Ray Computed
2
2006
2769
0.050
 Why?
Infusions, Intravenous
1
2024
428
0.050
 Why?
Sensitivity and Specificity
3
2018
1997
0.050
 Why?
Streptococcus pneumoniae
1
2025
184
0.050
 Why?
CD4-Positive T-Lymphocytes
1
2009
1140
0.050
 Why?
Nucleocapsid
1
2022
19
0.050
 Why?
Angiopoietins
2
2013
12
0.050
 Why?
Clinical Trials, Phase II as Topic
1
2022
75
0.050
 Why?
Cell Line, Transformed
2
2012
138
0.050
 Why?
Drug Combinations
1
2023
396
0.040
 Why?
Hemoglobins
1
2024
386
0.040
 Why?
Epigenomics
1
2022
114
0.040
 Why?
Feasibility Studies
1
2026
1111
0.040
 Why?
Granulomatosis with Polyangiitis
1
2002
47
0.040
 Why?
Blotting, Western
2
2016
1179
0.040
 Why?
Electroencephalography
1
2025
561
0.040
 Why?
Health Policy
1
2024
400
0.040
 Why?
Review Literature as Topic
1
2021
52
0.040
 Why?
Random Allocation
2
2012
365
0.040
 Why?
National Institutes of Health (U.S.)
1
2021
147
0.040
 Why?
Macrophages, Peritoneal
2
2012
89
0.040
 Why?
User-Computer Interface
1
2002
165
0.040
 Why?
Bronchoscopy
1
2002
227
0.040
 Why?
Drug Discovery
1
2021
153
0.040
 Why?
Antimalarials
1
2020
35
0.040
 Why?
HIV Infections
1
2016
3193
0.040
 Why?
Bayes Theorem
1
2022
420
0.040
 Why?
Airway Obstruction
1
2002
153
0.040
 Why?
Single-Blind Method
1
2020
318
0.040
 Why?
Netherlands
1
2018
84
0.040
 Why?
Case-Control Studies
1
2026
3623
0.030
 Why?
Disease Progression
1
2026
2864
0.030
 Why?
Ventricular Dysfunction, Right
1
2021
248
0.030
 Why?
Sleep
1
2025
888
0.030
 Why?
Epigenesis, Genetic
1
2022
679
0.030
 Why?
Prognosis
1
2026
4316
0.030
 Why?
Wounds and Injuries
1
2026
961
0.030
 Why?
Image Processing, Computer-Assisted
1
2002
779
0.030
 Why?
Clinical Trials as Topic
1
2022
1061
0.030
 Why?
Inflammation
3
2015
2878
0.030
 Why?
Congresses as Topic
1
2018
223
0.030
 Why?
ROC Curve
1
2018
617
0.030
 Why?
Bacterial Infections
1
2018
246
0.030
 Why?
Computational Biology
1
2021
669
0.030
 Why?
Risk Factors
2
2022
10885
0.030
 Why?
Virus Diseases
1
2018
216
0.030
 Why?
Graft Survival
1
2018
518
0.030
 Why?
Intercellular Adhesion Molecule-1
1
2016
132
0.030
 Why?
Cell Count
1
2016
319
0.030
 Why?
Cognition
1
2024
1266
0.030
 Why?
Receptors, Granulocyte Colony-Stimulating Factor
1
2015
1
0.030
 Why?
Cooperative Behavior
1
2018
462
0.030
 Why?
Ethnopsychology
1
2015
6
0.030
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
174
0.030
 Why?
Chemotaxis, Leukocyte
1
2015
114
0.030
 Why?
Microscopy, Confocal
1
2016
319
0.030
 Why?
Granulocyte Colony-Stimulating Factor
1
2015
90
0.030
 Why?
Cross-Cultural Comparison
1
2015
84
0.030
 Why?
Sputum
1
2016
302
0.030
 Why?
Cadherins
1
2016
200
0.030
 Why?
Respiratory Function Tests
1
2016
544
0.030
 Why?
Diagnosis, Differential
1
2018
1508
0.030
 Why?
Cell Lineage
1
2016
377
0.030
 Why?
Emergency Service, Hospital
1
2026
2381
0.030
 Why?
Immunocompromised Host
1
2015
202
0.030
 Why?
Environmental Monitoring
1
2016
346
0.020
 Why?
Influenza A Virus, H1N1 Subtype
1
2015
159
0.020
 Why?
Magnetic Resonance Imaging
1
2006
3904
0.020
 Why?
Adipose Tissue, White
1
2013
43
0.020
 Why?
Host-Pathogen Interactions
1
2016
361
0.020
 Why?
Benzylamines
1
2012
44
0.020
 Why?
Mice, Congenic
1
2012
23
0.020
 Why?
Cell Survival
1
2016
1100
0.020
 Why?
B7-2 Antigen
1
2012
27
0.020
 Why?
Heterocyclic Compounds
1
2012
23
0.020
 Why?
Adipose Tissue, Brown
1
2013
60
0.020
 Why?
RING Finger Domains
1
2012
4
0.020
 Why?
Chemokine CXCL12
1
2012
86
0.020
 Why?
Diet, Atherogenic
1
2011
6
0.020
 Why?
Chylomicrons
1
2011
18
0.020
 Why?
Lipoproteins, VLDL
1
2011
21
0.020
 Why?
Ventilators, Mechanical
1
2011
71
0.020
 Why?
Cyclic GMP
1
2011
90
0.020
 Why?
Myofibroblasts
1
2012
148
0.020
 Why?
Gene Expression
1
2016
1476
0.020
 Why?
Cross-Sectional Studies
1
2022
5904
0.020
 Why?
Cyclic AMP
1
2011
207
0.020
 Why?
Ventilator-Induced Lung Injury
1
2011
61
0.020
 Why?
Adenoviridae
1
2011
199
0.020
 Why?
Quality of Life
1
2023
3204
0.020
 Why?
Motor Activity
1
2015
718
0.020
 Why?
Down-Regulation
1
2012
618
0.020
 Why?
Trachea
1
2011
258
0.020
 Why?
Obesity
1
2022
3116
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2011
552
0.020
 Why?
Muscle Strength
1
2012
332
0.020
 Why?
Cardiovascular Diseases
1
2021
2187
0.020
 Why?
RNA, Small Interfering
1
2011
637
0.020
 Why?
Risk Assessment
1
2018
3747
0.020
 Why?
Multivariate Analysis
1
2012
1547
0.020
 Why?
Immunohistochemistry
1
2012
1716
0.020
 Why?
Young Adult
1
2024
14218
0.020
 Why?
Fibroblasts
1
2012
1025
0.020
 Why?
Cell Line
1
2012
2823
0.020
 Why?
Aged, 80 and over
1
2018
8333
0.010
 Why?
Postoperative Complications
1
2018
2970
0.010
 Why?
Proteins
1
2011
1023
0.010
 Why?
Cell Proliferation
1
2012
2507
0.010
 Why?
Adolescent
1
2024
22529
0.010
 Why?
Survival Rate
1
2009
2090
0.010
 Why?
Anti-Bacterial Agents
1
2015
1923
0.010
 Why?
RNA, Messenger
1
2011
2803
0.010
 Why?
Bronchography
1
2002
10
0.010
 Why?
Tracheal Stenosis
1
2002
39
0.010
 Why?
Observer Variation
1
2002
357
0.010
 Why?
Blood Glucose
1
2011
2341
0.010
 Why?
Insulin
1
2011
2512
0.010
 Why?
Signal Transduction
1
2012
5216
0.010
 Why?
Aggarwal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (337) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)